SRC and cancer: In addition, we demonstrated that the overexpression or knockdown of KRT19 regulated cancer stem cell reprogramming by modulating the expression of cancer stem cell markers (ALDH1, CXCR4, and CD133) as well as the level of p-Src and p-GSK3β (Tyr216).